# UK Investment Trusts: Latest News and Fund Manager Interviews – LWDB, FGT, RICA, BIOG, FSV

- Link: https://www.directorstalkinterviews.com/uk-investment-trusts-latest-news-and-fund-manager-interviews-lwdb-fgt-rica-biog-fsv/4121265712
- Published: 2026-10-09T09:07:06+01:00
- Author: Ethan Davis

UK investment trusts, all listed on the London Stock Exchange, continue to demonstrate
their versatility, delivering attractive long-term returns and giving investors 
access to a wide range of opportunities across major sectors, asset classes and 
investment styles.

In this article, DirectorsTalk interviews some of the leading managers of UK investment
trusts, highlighting the breadth of opportunities across global markets and sectors
and how experienced managers are positioning portfolios for the next phase of market
growth. Across the five interviews, the managers discuss themes including artificial
intelligence, UK corporate activity, biotechnology, global equity markets, capital
preservation and multi-asset investing, while also considering where valuation, 
income, resilience and long-term growth potential are creating attractive prospects
for investors.

**1. [Law Debenture](https://www.directorstalkinterviews.com/company/law-debenture-corporation-plc/lwdb.l):
Laura Foll on AI Fears and UK Takeover Opportunities**

Laura Foll explains how Law Debenture’s investment structure allows greater flexibility
to invest in recovery stocks and undervalued UK businesses. She discusses successful
investments in Rolls-Royce, Kier and Babcock, alongside new opportunities in RELX
and LSEG following concerns over AI disruption. With UK takeover activity accelerating,
Foll also examines portfolio changes, profit-taking and why consumer staples remain
underweight.

> [Law Debenture: Why AI fears and a UK takeover wave are reshaping Laura Foll’s portfolio (video)](https://www.directorstalkinterviews.com/law-debenture-why-ai-fears-and-a-uk-takeover-wave-are-reshaping-laura-foll-s-portfolio/4121260385)

**2. Finsbury Growth & Income Trust: Nick Train on AI and British Businesses**

Nick Train argues that artificial intelligence could increase the value of established
UK data businesses rather than undermine them. He explains the long-term investment
case for LSEG, RELX, Experian and Rightmove, alongside consumer brands including
Diageo and Unilever. The interview also covers new portfolio additions, TP ICAP 
and Games Workshop, and why UK equity valuations could attract further takeover 
interest.

> [Finsbury Growth & Income Trust Nick Train on Why AI Could Make UK Data Champions More Valuable (video)](https://www.directorstalkinterviews.com/finsbury-growth-income-trust-nick-train-on-why-ai-could-make-uk-data-champions-more-valuable-video/4121264744)

**3. Ruffer Investment Company: Jasmine Yeo on Protecting Capital in Volatile Markets**

Jasmine Yeo outlines Ruffer’s investment strategy, which prioritises protecting 
investors’ capital while seeking positive long-term returns. She explains how the
trust combines growth investments with defensive assets, including precious metals
and derivatives, to manage inflation, geopolitical uncertainty and market downturns.
The discussion also examines opportunities in UK and Chinese equities and why traditional
bonds may no longer provide reliable portfolio protection.

> [Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video)](https://www.directorstalkinterviews.com/ruffer-investment-company-why-defence-first-investing-is-winning-in-volatile-markets-video/4121236039)

**4. The Biotech Growth Trust: Josh Golomb on the Recovery in Biotechnology**

Josh Golomb discusses the recovery in biotechnology shares and why he believes the
sector has further potential. He highlights improving valuations, increasing pharmaceutical
takeover activity and reduced regulatory uncertainty as factors supporting renewed
investor interest. Particular attention is given to advances in cancer treatments,
including RAS inhibitors and daraxonrasib, which could improve treatment outcomes
for patients with pancreatic and other cancers.

> [The Biotech Growth Trust plc – Why Biotech’s Recovery Could Still Have Further to Run (video)](https://www.directorstalkinterviews.com/the-biotech-growth-trust-plc-why-biotech-s-recovery-could-still-have-further-to-run-video/4121263669)

**5. Fidelity Investment Companies: Opportunities Across Global Equity Markets**

Five Fidelity portfolio managers discuss investment opportunities across the UK,
Europe, China, Asia and emerging markets. The presentations explore attractive valuations,
overlooked smaller companies, China’s technological development, European dividend
growth and the potential for a recovery in UK equities. They also examine how AI,
interest rates and geopolitical developments are influencing investment decisions,
with an emphasis on disciplined stock selection and diversification.

> [Watch Fidelity present investments in UK, Europe, Emerging Markets, Asia and China (video)](https://www.directorstalkinterviews.com/watch-fidelity-present-investments-in-uk-europe-emerging-markets-asia-and-china-video/4121259935)

Share on:
